Camber Pharma Launches Generic Urocit-K®

Piscataway, NJ, April 8, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Potassium Citrate ER Tablets, which is the generic version of Urocit-K®
Potassium Citrate ER Tablets are used to treat a kidney stone condition called renal tubular acidosis.
Potassium Citrate ER Tablets are available from Camber in 5 mEq, 10mEq and 15 mEq – 100 count bottles.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection